Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective

This study only included people with rheumatoid arthritis or osteoarthritis. The results might be different if people with other conditions had been included. Other medical problems. The risks and benefits of celecoxib in people with other medical problems (such as significant kidney disease) are uncertain because this study excluded them. Other medical treatments. All patients in this study took a medication to protect the stomach; outside of studies, that’s not always the case. While these issues are valid, I think this study does provide a significant measure of reassurance regarding the cardiovascular risks of celecoxib. And it may encourage doctors who thought the drug was too risky to prescribe it more often. This new research shows in a dramatic way why “more research is needed” is not just a tagline at the end of so many medical news stories. And in the case of celecoxib, the result of the additional research is good news indeed. The post Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective appeared first on Harvard Health Blog.
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Arthritis Drugs and Supplements Health Heart Health Pain Management Source Type: blogs